Ikezawa Z, Arden B, Nagy Z A, Klein J
Eur J Immunol. 1984 Aug;14(8):681-6. doi: 10.1002/eji.1830140802.
Mouse hybridomas generated by fusion between a lactate dehydrogenase-B (LDH-B)-specific B10.A(2R) T suppressor (Ts) cell line and the BW5147 thymoma secrete two suppressor factors, TsF-A and TsF-E. The factors carry the same antigen-binding chains but different major histocompatibility complex (MHC) chains (A beta-like and E beta-like, respectively). The TsF-A suppresses the proliferation of A-restricted, LDH-B-specific T helper (Th) cells. In this report we demonstrate that the addition of the TsF-E (isolated on immunosorbent columns with Ek- or Jk-specific antibodies) to the culture of LDH-B-primed B10.A(2R) lymph node cells turns the nonresponder (suppressed) cultures into proliferating ones, and that this change is antigen specific. This enhancing effect occurs in the early phase of the cell culture; the factor has no effect when added 2 days after the initiation of the culture. Because pretreatment of the Ly-2+ but not of the Ly-1+2- cells with TsF-E induces responsiveness, it is very likely that the targets of the factor are the Ts cells or their precursors that belong to the Ly-2+ subset. An incubation period of about 4 h is necessary for the TsF-E to exert its action. The enhancing effect of the TsF-E is abrogated by monoclonal antibodies specific for Ek and Jk antigenic determinants. However, only some of the antibodies that retain the TsF-E on the immunosorbent column neutralize the factor in a functional test. Antibody blocking studies also indicate that the MHC determinants involved in the interaction between the antigen-presenting and the Ts cell during Ts cell activation, and in the TsF-E Ts cell interaction are either very similar or identical. We interpret the data as indicating that the Ts cells or their precursors recognize the TsF-E with the same receptors as they use for the recognition of LDH-B together with the Ek on the antigen-presenting cells. The recognition of the TsF-E inactivates the Ts cell so that proliferation of Th cells then occurs unhindered. Thus, the production of the TsF-E may provide a feedback mechanism that regulates the activation of the Ts cells and, consequently, the degree of suppression in the response to LDH-B.
由乳酸脱氢酶-B(LDH-B)特异性的B10.A(2R) T抑制(Ts)细胞系与BW5147胸腺瘤融合产生的小鼠杂交瘤分泌两种抑制因子,即TsF-A和TsF-E。这些因子携带相同的抗原结合链,但主要组织相容性复合体(MHC)链不同(分别为Aβ样和Eβ样)。TsF-A抑制受A限制的、LDH-B特异性T辅助(Th)细胞的增殖。在本报告中,我们证明,将TsF-E(用Ek或Jk特异性抗体在免疫吸附柱上分离得到)添加到用LDH-B致敏的B10.A(2R)淋巴结细胞培养物中,可使无反应(受抑制)的培养物转变为增殖培养物,且这种变化具有抗原特异性。这种增强作用发生在细胞培养的早期阶段;在培养开始2天后添加该因子则无作用。由于用TsF-E预处理Ly-2+细胞而非Ly-1+2-细胞可诱导反应性,所以该因子的靶细胞很可能是属于Ly-2+亚群的Ts细胞或其前体。TsF-E发挥其作用需要约4小时的潜伏期。TsF-E的增强作用可被针对Ek和Jk抗原决定簇的单克隆抗体消除。然而,在功能试验中,只有一些能将TsF-E保留在免疫吸附柱上的抗体能中和该因子。抗体阻断研究还表明,在Ts细胞激活过程中抗原呈递细胞与Ts细胞之间相互作用以及TsF-E与Ts细胞相互作用中涉及的MHC决定簇非常相似或相同。我们将这些数据解释为表明Ts细胞或其前体识别TsF-E时所用的受体与它们识别抗原呈递细胞上的LDH-B和Ek时所用的受体相同。对TsF-E的识别使Ts细胞失活,从而使Th细胞的增殖不受阻碍地发生。因此,TsF-E的产生可能提供一种反馈机制,调节Ts细胞的激活,进而调节对LDH-B反应中的抑制程度。